» Articles » PMID: 20299300

The Indeterminate Adrenal Lesion

Overview
Journal Cancer Imaging
Publisher Springer Nature
Specialties Oncology
Radiology
Date 2010 Mar 20
PMID 20299300
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

With the increasing use of abdominal cross-sectional imaging, incidental adrenal masses are being detected more often. The important clinical question is whether these lesions are benign adenomas or malignant primary or secondary masses. Benign adrenal masses such as lipid-rich adenomas, myelolipomas, adrenal cysts and adrenal haemorrhage have pathognomonic cross-sectional imaging appearances. However, there remains a significant overlap between imaging features of some lipid-poor adenomas and malignant lesions. The nature of incidentally detected adrenal masses can be determined with a high degree of accuracy using computed tomography (CT) and magnetic resonance imaging (MRI) alone. Positron emission tomography (PET) is also increasingly used in clinical practice in characterizing incidentally detected lesions. We review the performance of the established and new techniques in CT, MRI and PET that can be used to distinguish benign adenomas and malignant lesions of the adrenal gland.

Citing Articles

Prediction of 2-[F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study.

Stanzione A, Cuocolo R, Bombace C, Pesce I, Mainolfi C, De Giorgi M Cancers (Basel). 2023; 15(13).

PMID: 37444549 PMC: 10340369. DOI: 10.3390/cancers15133439.


Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding.

Younes N, Bourdeau I, Olney H, Perrotte P, Prosmanne O, Latour M Endocr Oncol. 2023; 1(1):K7-K12.

PMID: 37435185 PMC: 10265540. DOI: 10.1530/EO-21-0031.


The True Value of Quantitative Imaging for Adrenal Mass Characterization: Reality or Possibility?.

Stanzione A, Romeo V, Maurea S Cancers (Basel). 2023; 15(2).

PMID: 36672470 PMC: 9857152. DOI: 10.3390/cancers15020522.


Distinguishing between metastatic and benign adrenal masses in patients with extra-adrenal malignancies.

Chen J, He Y, Zeng X, Zhu S, Li F Front Endocrinol (Lausanne). 2022; 13:978730.

PMID: 36246921 PMC: 9554709. DOI: 10.3389/fendo.2022.978730.


Radiomics approach based on biphasic CT images well differentiate "early stage" of adrenal metastases from lipid-poor adenomas: A STARD compliant article.

Cao L, Xu W Medicine (Baltimore). 2022; 101(38):e30856.

PMID: 36197274 PMC: 9509040. DOI: 10.1097/MD.0000000000030856.


References
1.
Song J, Chaudhry F, Mayo-Smith W . The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008; 190(5):1163-8. DOI: 10.2214/AJR.07.2799. View

2.
Inan N, Arslan A, Akansel G, Anik Y, Balci N, Demirci A . Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses. Eur J Radiol. 2007; 65(1):154-62. DOI: 10.1016/j.ejrad.2007.03.012. View

3.
Boland G, Blake M, Holalkere N, Hahn P . PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol. 2009; 192(4):956-62. DOI: 10.2214/AJR.08.1431. View

4.
Groussin L, Bonardel G, Silvera S, Tissier F, Coste J, Abiven G . 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab. 2009; 94(5):1713-22. DOI: 10.1210/jc.2008-2302. View

5.
Halefoglu A, Bas N, Yasar A, Basak M . Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study. Eur J Radiol. 2009; 73(3):643-51. DOI: 10.1016/j.ejrad.2008.12.010. View